V Barbour. Show Affiliations »
Abstract
Mesh: See more » AdolescentClinical Trials as TopicGenetic Therapy/adverse effectsHumansMaleOrnithine Carbamoyltransferase Deficiency Disease/therapyPatient SelectionUnited StatesUnited States Food and Drug Administration
Year: 2000 PMID: 10665565 DOI: 10.1016/S0140-6736(05)74011-3
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321